VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | Bi-specific antibodies in HER2+ gastric cancer

Hyun C. Chung, MD, PhD, Yonsei Cancer Center, Seoul, Republic of Korea, provides an overview of ongoing studies in patients with HER2+ gastric cancer, including the use of novel immunotherapy and bi-specific antibodies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter